Masako Tomoyasu

708 total citations
10 papers, 574 citations indexed

About

Masako Tomoyasu is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Masako Tomoyasu has authored 10 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Masako Tomoyasu's work include Diabetes Treatment and Management (6 papers), Peptidase Inhibition and Analysis (2 papers) and Pancreatic function and diabetes (2 papers). Masako Tomoyasu is often cited by papers focused on Diabetes Treatment and Management (6 papers), Peptidase Inhibition and Analysis (2 papers) and Pancreatic function and diabetes (2 papers). Masako Tomoyasu collaborates with scholars based in Japan and United States. Masako Tomoyasu's co-authors include Tsutomu Hirano, Michishige Terasaki, Takuya Watanabe, Masaharu Nagashima, Kyoko Nohtomi, Ayumi Miyazaki, Joo‐ri Kim‐Kaneyama, Makoto Ohara, Takeshi Yamamoto and Tomoyasu Fukui and has published in prestigious journals such as PLoS ONE, Diabetologia and Diabetes Research and Clinical Practice.

In The Last Decade

Masako Tomoyasu

10 papers receiving 567 citations

Peers

Countries citing papers authored by Masako Tomoyasu

Since Specialization

Citations

This map shows the geographic impact of Masako Tomoyasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masako Tomoyasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masako Tomoyasu more than expected).

Fields of papers citing papers by Masako Tomoyasu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masako Tomoyasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masako Tomoyasu. The network helps show where Masako Tomoyasu may publish in the future.

Co-authorship network of co-authors of Masako Tomoyasu

This figure shows the co-authorship network connecting the top 25 collaborators of Masako Tomoyasu. A scholar is included among the top collaborators of Masako Tomoyasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masako Tomoyasu. Masako Tomoyasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Prospective randomized comparative study of the effect of pemafibrate add‐on or double statin dose on small dense low‐density lipoprotein‐cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy 2023 ·Journal of Diabetes Investigation ·Tsutomu Hirano, Toshiyuki Hayashi, (unknown), Atsuko Tamasawa, Satoshi Goto, Masako Tomoyasu, Takeshi Yamamoto, Makoto Ohara, Michishige Terasaki, Hideki Kushima, Yasuki Ito, Sho‐ichi Yamagishi, Yusaku Mori	3
2	Pheochromocytoma presenting with severe hyperglycemia and metabolic acidosis following intra-articular glucocorticoid administration: a case report 2019 ·Journal of Medical Case Reports ·Masako Tomoyasu, Yusaku Mori, (unknown), Hideki Kushima, Tsutomu Hirano	5
3	Effect of Dulaglutide Versus Liraglutide on Glucose Variability, Oxidative Stress, and Endothelial Function in Type 2 Diabetes: A Prospective Study 2019 ·Diabetes Therapy ·(unknown), Makoto Ohara, (unknown), Munenori Hiromura, Masako Tomoyasu, (unknown), Takeshi Yamamoto, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano	22
4	Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study 2018 ·Diabetes Research and Clinical Practice ·Saki Yamamoto, Toshiyuki Hayashi, Makoto Ohara, Satoshi Goto, Jun Sato, (unknown), (unknown), Nobuko Sato, Munenori Hiromura, Masako Tomoyasu, Noriko Nakanishi, (unknown), (unknown), Takeshi Yamamoto, Tomoyasu Fukui, Tsutomu Hirano	11
5	Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes 2018 ·Diabetes Research and Clinical Practice ·Makoto Ohara, (unknown), Satoshi Goto, (unknown), (unknown), Masako Tomoyasu, Takeshi Yamamoto, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano	45
6	Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin 2017 ·Cardiovascular Diabetology ·Toshiyuki Hayashi, Tomoyasu Fukui, Noriko Nakanishi, Saki Yamamoto, Masako Tomoyasu, (unknown), Makoto Ohara, Takeshi Yamamoto, Yasuki Ito, Tsutomu Hirano	151
7	Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models 2016 ·Circulation Journal ·Munenori Hiromura, Yusaku Mori, (unknown), Michishige Terasaki, (unknown), Takaharu Negoro, (unknown), (unknown), (unknown), Rena Watanabe, Kengo Sato, Hideki Kushima, Masako Tomoyasu, Yasuko Nakano, Yuichiro Yamada, Takuya Watanabe, Tsutomu Hirano	38
8	A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice 2015 ·Journal of Atherosclerosis and Thrombosis ·(unknown), Munenori Hiromura, Yusaku Mori, Michishige Terasaki, Takuya Watanabe, Hideki Kushima, (unknown), Masako Tomoyasu, Masaharu Nagashima, Tsutomu Hirano	26
9	Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice 2013 ·PLoS ONE ·Michishige Terasaki, Masaharu Nagashima, Kyoko Nohtomi, (unknown), Masako Tomoyasu, (unknown), (unknown), Yuki Katayama, Kengo Sato, Fumiko Itoh, Takuya Watanabe, Tsutomu Hirano	64
10	Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice 2011 ·Diabetologia ·Masaharu Nagashima, Takuya Watanabe, Michishige Terasaki, Masako Tomoyasu, Kyoko Nohtomi, Joo‐ri Kim‐Kaneyama, Ayumi Miyazaki, Tsutomu Hirano	209

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact